Accelerate Diagnostics Inc. logo

Accelerate Diagnostics Inc. (AXDX)

Delisted
NASDAQ (CM) NASDAQ (CM)
Want to track AXDX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Accelerate Diagnostics, Inc. (AXDX) Q3 2024 Earnings Call Transcript

Accelerate Diagnostics, Inc. (AXDX) Q3 2024 Earnings Call Transcript

Accelerate Diagnostics, Inc. (NASDAQ:AXDX ) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET Company Participants Laura Pierson - Investor Relations Officer Jack Phillips - President and Chief Executive Officer David Patience - Chief Financial Officer Conference Call Participants Operator Good day, and welcome to the Accelerate Diagnostics Inc. Third Quarter 2024 Earnings Conference Call. All participants will be in a listen-only mode.

Seekingalpha | 1 year ago
Accelerate Diagnostics (AXDX) Reports Q3 Loss, Lags Revenue Estimates

Accelerate Diagnostics (AXDX) Reports Q3 Loss, Lags Revenue Estimates

Accelerate Diagnostics (AXDX) came out with a quarterly loss of $0.59 per share versus the Zacks Consensus Estimate of a loss of $0.47. This compares to loss of $0.92 per share a year ago.

Zacks | 1 year ago
Accelerate Diagnostics Stock Down Despite FDA Clearance for Arc System

Accelerate Diagnostics Stock Down Despite FDA Clearance for Arc System

AXDX's Arc system gains FDA clearance, automating blood culture prep for faster microbial ID, improved sepsis outcomes and reduced hospital costs.

Zacks | 1 year ago
Accelerate Diagnostics (AXDX) Completes WAVE Pre-Clinical Trial

Accelerate Diagnostics (AXDX) Completes WAVE Pre-Clinical Trial

Accelerate Diagnostics (AXDX) is confident about WAVE product design and the system's capabilities after the successful completion of the pre-clinical trial.

Zacks | 1 year ago
Accelerate Diagnostics, Inc. (AXDX) Q2 2024 Earnings Call Transcript

Accelerate Diagnostics, Inc. (AXDX) Q2 2024 Earnings Call Transcript

Accelerate Diagnostics, Inc. (NASDAQ:AXDX ) Q2 2024 Earnings Conference Call August 8, 2024 4:30 PM ET Company Participants Laura Pierson - Investor Relations Officer Jack Phillips - President and CEO David Patience - Chief Financial Officer Conference Call Participants Andrew Brackmann - William Blair Operator Good day. And welcome to the Accelerate Diagnostics Incorporated Second Quarter 2024 Results Conference Call.

Seekingalpha | 1 year ago
Accelerate Diagnostics (AXDX) Reports Q2 Loss, Misses Revenue Estimates

Accelerate Diagnostics (AXDX) Reports Q2 Loss, Misses Revenue Estimates

Accelerate Diagnostics (AXDX) came out with a quarterly loss of $0.50 per share versus the Zacks Consensus Estimate of a loss of $0.55. This compares to loss of $2.36 per share a year ago.

Zacks | 1 year ago
Dead Cat Bounce: 3 Stocks to Sell Before They Plunge Again

Dead Cat Bounce: 3 Stocks to Sell Before They Plunge Again

A dead cat bounce is when a falling stock sees a short-term recovery, but is ultimately likely to head lower. It comes from the idea that “even a dead cat will bounce if it falls from a great height.

Investorplace | 1 year ago